Amway (Malaysia) Holdings

AMWAY

MYL6351OO000

Pharmaceuticals

End-of-day quote BURSA MALAYSIA Other stock markets 03:30:00 25/06/2024 am IST			5-day change	1st Jan Change
7.1 ^MYR	-1.25%		-1.93%	+20.75%

24/05	Amway Malaysia Posts Higher Attributable Income In Fiscal Q1	MT
23/05	Amway Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Amway Holdings Berhad Declares First Single Tier Interim Dividend for the Financial Year Ending 31 December 2024, Payable on 21 June 2024

May 23, 2024 at 06:03 pm IST

Amway (Malaysia) Holdings Berhad declared first single tier interim dividend of 5.0 sen net per share for the financial year ending 31 December 2024. Ex-Date 07 June 2024, Ex-Date 07 June 2024 and Payment Date 21 June 2024.

Latest news about Amway (Malaysia) Holdings

Amway Malaysia Posts Higher Attributable Income In Fiscal Q1	24/05	MT
Amway Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05	CI
Amway Holdings Berhad Declares First Single Tier Interim Dividend for the Financial Year Ending 31 December 2024, Payable on 21 June 2024	23/05	CI
Amway Holdings Berhad Appoints Datuk Harjeet Singh A/L Hardev Singh as Independent and Non Executive Member of Audit Committee	23/05	CI
Amway Holdings Berhad Appoints Datuk Harjeet Singh A/L Hardev Singh as Independent and Non Executive Member of Nomination Committee	23/05	CI
Amway Holdings Berhad Appoints Datuk Harjeet Singh A/L Hardev Singh as Independent and Non Executive Director	23/05	CI
Amway Holdings Berhad Announces Retirement of Dato' Abdullah Thalith Bin Md Thani as Independent and Non Executive Member of Audit Committee, Effective 23 May 2024	23/04	CI
Amway Holdings Berhad Announces Retirement of Dato' Abdullah Thalith Bin Md Thani as Independent and Non Executive Director, Effective 23 May 2024	23/04	CI
Amway Holdings Berhad Announces Re-Designation of Datin Seri Azreen Binti Abu Noh as Independent and Non Executive Chairman of Nomination Committee, Effective 23 May 2024	23/04	CI
Amway Holdings Berhad Announces Retirement of Dato' Abdullah Thalith Bin Md Thani as Independent and Non Executive Chairman of Nomination Committee, Effective 23 May 2024	23/04	CI
Malaysian Shares Rebound on Bargain Hunting; Chin Hin Group Property's Shares Rally 9%	04/04	MT
Malaysian Shares End in Red After Volatile Trading Session; Amway (Malaysia)'s Shares Drop Over 7%	03/04	MT
Malaysian Shares Maintain Winning Streak; Shares of Ge-Shen Rally 10%	02/04	MT
Malaysian Shares Starts Week in Green; Vstecs' Shares Rally Over 8%	04/03	MT
Amway Holdings Berhad Declares Fourth Single Tier Interim Dividend for the Financial Year Ending 31 December 2023, Payable on 27 March 2024	28/02	CI
Amway Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02	CI
Amway Holdings Berhad Announces the Resignation of Puan Aida Binti Md Daud as Non Independent and Non Executive Director	29/12	CI
Amway Holdings Berhad Appoints Puan Norhanifah Binti A. Jalil as Non Independent and Non Executive Director	29/12	CI
Amway (Malaysia) Logs Higher Profit in Q3	16/11	MT
Amway Holdings Berhad Declares Third Single Tier Interim Dividend for the Financial Year Ending 31 December 2023, Payable on 15 December 2023	15/11	CI
Amway Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Amway Holdings Berhad Announces the Resignation of WONG WAI FOONG as Company Secretary	15/11	CI
Amway Holdings Berhad Appoints JOANNE TOH JOO ANN as Company Secretary	15/11	CI
Amway (Malaysia) Logs Higher Profit in Q2	24/23/24	MT
Amway Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23/23/23	CI

Chart Amway (Malaysia) Holdings

Duration

Period

More charts

Company Profile

Amway (Malaysia) Holdings Berhad is a Malaysia-based investment holding company, which is engaged in the distribution of consumer products under the Amway trademark. The Company's product range includes health supplements and energy products to skincare, personal care, and durables. The Company is engaged in the direct selling of consumer products, primarily under the Amway trademark. The Company's product range includes health supplements and energy products to skincare, personal care, and durables. The Company manufactures and distributes approximately 450 consumer products. The Company has approximately 20 stores nationwide. The Company's brands include Nutrilite vitamin, mineral and dietary supplements; XS sports nutrition; ARTISTRY skincare products and color cosmetics; the eSpring water treatment system; G&H; Bodykey by Nutrilite; GLISTER; SATINIQUE; the L.O.C household cleaning products. Amway (Malaysia) Sdn. Bhd. is a subsidiary of the Company.

Sector

Pharmaceuticals

Calendar

21/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Amway (Malaysia) Holdings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

7.1 MYR

Average target price

7.05 MYR

Spread / Average Target

-0.70%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AMWAY (MALAYSIA) HOLDINGS	+20.75%	25Cr
ELI LILLY AND COMPANY	+55.19%	81TCr
NOVO NORDISK A/S	+45.37%	65TCr
JOHNSON & JOHNSON	-6.09%	35TCr
MERCK & CO., INC.	+21.92%	34TCr
ASTRAZENECA PLC	+19.59%	25TCr
ROCHE HOLDING AG	+3.52%	23TCr
NOVARTIS AG	+14.02%	22TCr
AMGEN INC.	+10.86%	17TCr
PFIZER, INC.	-2.78%	16TCr

Other Pharmaceuticals

Amway (Malaysia) Holdings

Equities

AMWAY

MYL6351OO000

Pharmaceuticals

Amway Holdings Berhad Declares First Single Tier Interim Dividend for the Financial Year Ending 31 December 2024, Payable on 21 June 2024

Latest news about Amway (Malaysia) Holdings

Chart Amway (Malaysia) Holdings

Company Profile

Income Statement Evolution

Ratings for Amway (Malaysia) Holdings

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals